Brixmor Property Group, Inc. (BRX)

12.71
0.00 (0.00)
NYSE
Prev Close 12.71
Open 12.84
Day Low/High 12.71 / 12.90
52 Wk Low/High 7.51 / 22.74
Volume 120.92K
Exchange NYSE
Shares Outstanding 296.48B
Market Cap 3.67B
P/E Ratio 17.42
Div & Yield N.A. (N.A)

Latest News

Brixmor Property Group Suffers From a Lot of Chart Resistance

Brixmor Property Group Suffers From a Lot of Chart Resistance

Let's review the charts and indicators to see if an opportunity exists here.

Cramer: Another Reason to Be Skeptical of the Government

Cramer: Another Reason to Be Skeptical of the Government

Numbers on industrial production and retail sales don't tell the real story.

Jim Cramer Says Qualcomm's Deal for NXP Is "Brilliant," Stock Can Go Higher

Jim Cramer Says Qualcomm's Deal for NXP Is "Brilliant," Stock Can Go Higher

The biggest semiconductor deal ever provides opportunities for investors, according to Jim Cramer.

Brixmor Property Tanks on Accounting Issues, Jim Cramer Says Avoid It

Brixmor Property Tanks on Accounting Issues, Jim Cramer Says Avoid It

Shares of Brixmor Property Group tanked on Monday after three of its top executives resigned following an accounting review.

REIT Fundamentals Strong, Occupancy Up Says Brixmor CFO

REIT Fundamentals Strong, Occupancy Up Says Brixmor CFO

Concerns about higher interest rates ahead may be weighing on publicly traded REIT shares, but from an operating perspective REITs are breaking out.

Two on My Bullish Crossover List

Two on My Bullish Crossover List

These REITs show positive price action and good technical indications.

Retail Retreat Not Worrying Brixmor CEO

Retail Retreat Not Worrying Brixmor CEO

Brixmor's grocery-anchored shopping centers have been outperforming despite the recent worries in the retail space, says the company's CEO Michael Carroll.

Brixmor Property Group initiated at UBS

Brixmor IPO Shops More Shares

Brixmor IPO Shops More Shares

Brixmor CEO Michael Carroll talks to TheStreet about its increased offering and its generous dividend.

Millions for Fish Oil

Millions for Fish Oil

Stocks are up as AstraZeneca pays millions for Omthera, while Valeant buys Bausch & Lomb and Tiffany's earnings shine.